Sol-Gel Technologies (SLGL) fell ~10% in the premarket on Wednesday after the dermatological drug developer announced that ...

We explore the disconnect between mycological cure and cosmetic recovery in Tinea Versicolor, focusing on managing patient ...

Adult-onset Still's disease (AOSD) is a rare inflammatory disorder. Thanks to a new initiative, AOSD is now considered to be ...

As a kidney transplant recipient, Paris Malachias was accustomed to dealing with skin cancer. But when a biopsy showed that ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) to ...

Vanda Pharma submits BLA to US FDA for imsidolimab to treat generalized pustular psoriasis: Washington Tuesday, December 16, 2025, 15:00 Hrs [IST] Vanda Pharmaceuticals Inc., (Van ...

Please don’t give up, as we will stay with you until the end.” These were the words spoken by medical staff at Seoul Asan ...

Investing.com -- Vanda Pharmaceuticals Inc (NASDAQ:VNDA) stock jumped 5.1% Monday after the company announced it submitted a Biologics License Application (BLA) to the FDA for imsidolimab, a treatment ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the submission of a Biologics License Application (BLA) ...

Vanda Pharmaceuticals shares rose after the company said it had submitted a biologics license application to the Food and Drug Administration for its generalized pustular psoriasis treatment. The ...

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced activation of The University of Texas Medical Branch (UTMB) in ...

Ruxolitinib cream demonstrated favorable safety and efficacy in pediatric atopic dermatitis, highlighting JAK inhibitors' ...